Schedule 13D ownership disclosure
TEVOGEN BIO HLDGS INC
Common Stock, par value $0.0001 per share · CUSIP: 88165K200
Event date: 2026-11-02
- Filing-level shares
- 61,709,567.00
- Percent of class
- 91.1%
- Saadi Ryan H.Reported CIK 0002011728
Shares: 61,709,567.00 · Class: 91.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-049973
- Form type
- SCHEDULE 13D/A
- Filer
- Saadi Ryan H.
- CIK
- CIK 2011728
- Filed
- Nov 04, 2026
- Reporting period
- Nov 02, 2026
- Description
- Schedule 13D beneficial ownership